Pre-Event Teaser:

 

Respiratory Drugs Hybrid Summit: from Development to Delivery

9 June 2022 - Online
14:00 - 16:30 CET | 8:00 - 10:30 EST
REGISTER FOR FREEACCESS MATERIALSMAIN EVENT
-107Days -5Hours -30Minutes -48Seconds

ABOUT THE EVENT

In preparation for our innovative Respiratory Drugs Hybrid Summit: from Development to Delivery taking place in 13-14 October, we are delighted to introduce this Pre-Event “Teaser” webinar -FREE for all!

With so many challenges to face when bringing respiratory products to market, we are providing an inside-industry look at this important topic with top Pharma, biotech, medical devices manufacturers, regulatory bodies, solution providers and research institutes. This Pre-Event webinar enables you to have a sneak peek at the premier topics from our expert speakers for the main event: ‘Respiratory Drugs Hybrid Summit’ on 13-14 October, 2022.

EVERYONE IS WELCOME AS WE HAVE 500 SEATS. DON’T MISS THIS PRE-EVENT TEASER AND NETWORK WITH THE INDUSTRY LEADERS!

SPEAKERS

Amrit Paudel

Scientific leader

Dr. Amrit Paudel is an assistant professor at Graz University of technology and scientific leader of formulation drug delivery at Research Center Pharmaceutical Engineering (RCPE), Graz, Austria.  Amrit worked for some years in the discovery pharmaceutics team of Bristol-Myers Squibb. He completed his Ph.D. in 2013 in the drug delivery and disposition group at the University of Leuven, Belgium. He is the recipient of the Young Investigator Award of 2014, issued by the APGI. Dr. Paudel has a broad interest in the physical chemistry of formulations, drug delivery, and pharmaceutical material engineering. His current work involves predictive knowledge/model development for the stability of pharmaceutical products. In addition, particle design and engineering of an oral as well as pulmonary drug delivery, are of his key interests.

Nélio Drumond

Senior Principal Scientist

Nélio Drumond is a PharmD by training with a PhD in Patient Centric Drug Product Design. He shares several years of experience in the Pharmaceutical Industry providing scientific leadership to govern the formulation and manufacturing strategies for drug product development projects during clinical stages, including their subsequent scalability and validation for commercial use. Currently, Dr. Drumond is responsible for the technical management and leadership of commercial manufacturing activities at different Contract Manufacturing Organizations (CMOs) for an established portfolio of Takeda products within the European region.

Vivek Gupta

Associate Professor & Associate Dean

Vivek Gupta is an Associate Professor, and Associate Dean of Graduate Education & Research at St. John’s University College of Pharmacy. Dr Gupta is an experienced pharmaceutical researcher with interests in developing novel therapies for respiratory disorders. His expertise lies in the fields of novel drug discovery and repurposing, and non-invasive delivery of small and macromolecules via inhalation route. He also has significant research interest in the fields of pharmaceutical scalability, and nano-repurposing. Dr. Gupta’s research group has published >75 high-impact studies in peer reviewed journals. Dr. Gupta also serves on editorial boards of many peer-reviewed journals; and is also involved in national pharmaceutical organizations including AAPS and CRS. Multiple technologies and therapies developed by Dr. Gupta’s group have been patented and have been licensed to biotech start-ups including PulmoSIM Therapeutics.11:39 am

Graham Paul

Director, Toxicology

Graham is a general toxicologist currently supporting development of cannabinoid medicines at Jazz Pharmaceuticals.
His career began in contract research, directing inhalation toxicology studies with industrial chemicals and agrochemical products. Progressing into the pharmaceutical sector in 2001, Graham worked in early and later-stage drug development at Novartis Pharma (Switzerland) and then GSK (UK), where he supported non-clinical safety with a focus on respiratory drug development and technical development of inhalation delivery systems until 2021.
Graham graduated from the University of Birmingham (UK) with a BSc in Biochemistry and MSc in Toxicology and completed his PhD with Cardiff University on the topic of “dosimetry and implications for aerosol presentation for non-clinical development of respiratory drugs”. He is a Fellow of the Royal Society of Biology and a European Registered Toxicologist.

Dr. Andrew Feilden

European Extractable and Leachable Strategic Director

Hall Analytical Laboratories Limited are a contract analytical laboratory specialising in Mass Spectrometry.
Our skill within the Mass Spectrometry field has allowed us to support clients within a wide range of market sectors including Pharmaceuticals, Tobacco, Next Generation Nicotine products, Consumer products, Polyurethane Foam, Agrochemicals, Persistent Organic Pollutants and much more.

SPONSORS

Silver Sponsor

MEDIA PARTNERS

client
client
client
client
client
client
client
CONFERENCE PLATFORM

HOPIN

  • Network one-on-one over live video.
  • “Connect” and exchange virtual business cards for following up later.
  • Join breakout sessions and participate in groups.
  • Watch keynote presentations on stage, send chat messages, fill out polls, and explore interactive expo areas.

More details: www.hopin.com